Sales decline 56.47% to Rs 11.44 crore
Net Loss of Bafna Pharmaceuticals reported to Rs 8.37 crore in the quarter ended March 2017 as against net loss of Rs 6.85 crore during the previous quarter ended March 2016. Sales declined 56.47% to Rs 11.44 crore in the quarter ended March 2017 as against Rs 26.28 crore during the previous quarter ended March 2016.For the full year,net loss reported to Rs 18.47 crore in the year ended March 2017 as against net loss of Rs 12.18 crore during the previous year ended March 2016. Sales declined 23.86% to Rs 64.96 crore in the year ended March 2017 as against Rs 85.32 crore during the previous year ended March 2016.
ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales11.4426.28 -56 64.9685.32 -24 OPM %-52.80-9.47 --8.043.31 - PBDT-8.20-5.89 -39 -15.42-8.41 -83 PBT-9.05-7.66 -18 -19.31-12.52 -54 NP-8.37-6.85 -22 -18.47-12.18 -52
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
